FindTrial
Sign In

ROLE OF 25% DEXTROSE PROLOTHERAPY VERSUS EXTRA CORPOREAL SHOCKWAVE therapy in the treatment of chronic lateral epicondylitis

Comparison between prolotherapy using 25% dextrose and extracorporeal shock wave therapy in the management of pain and improving functional outcome in patients suffering from chronic lateral epicondylitis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/10/021802
Enrollment
84
Registered
2019-10-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M771- Lateral epicondylitis

Interventions

Intervention1: prolotherapy: prolotherapy using 25% dextrose(2ml) at tender lateral epicondyle in patients suffering from chronic lateral epicondylitis Control Intervention1: ESWT: ESWT in tender late

Sponsors

DEBASISH DEB
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Duration of symptoms for at least 6 months Failed conservative treatment Willingness to comply with treatment and follow-up assessment

Exclusion criteria

Exclusion criteria: Duration of symptoms less than 6 months History of previous surgery in the same tendon Implanted hardware adjacent to the target treatment region Abnormal radiographic findings like Osteophtyes, Calcification, or Exostosis pregnancy Diabetes Cancer

Design outcomes

Primary

MeasureTime frame
improvement in pain in terms of VAS improvement in functional outcome in terms of Grip strengthTimepoint: BASELINE, 1MONTH, 3MONTH, 6MONTH—

Secondary

MeasureTime frame
grip srtength assessmentTimepoint: at baseline, 1month,3 month, 6month—

Countries

India

Contacts

Public ContactDEBASISH DEB

REGIONAL INSTITUTE OF MEDICAL SCIENCES MANIPUR

bimoldr@yahoo.com9436070652

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026